{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:16Z","timestamp":1787729476894,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T00:00:00Z","timestamp":1359331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T00:00:00Z","timestamp":1359331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s12325-013-0004-9","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T18:18:49Z","timestamp":1359483529000},"page":"102-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy"],"prefix":"10.1007","volume":"30","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,28]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0447.2010.01645.x","volume":"123","author":"TA Ketter","year":"2011","unstructured":"Ketter TA, Citrome L, Wang PW, Culver JL, Srivastava S. Treatments for bipolar disorder: can number needed to treat\/harm help inform clinical decisions? Acta Psychiatr Scand. 2011;123:175\u2013189.","journal-title":"Acta Psychiatr Scand"},{"key":"4_CR2","first-page":"83","volume-title":"Handbook of Diagnosis and Treatment of Bipolar Disorder","author":"TA Ketter","year":"2010","unstructured":"Ketter TA, Wang PW. Chapter 5: Overview of pharmacotherapy for bipolar disorders. In: Ketter TA. Handbook of Diagnosis and Treatment of Bipolar Disorder. Washington, DC: American Psychiatric Publishing, Inc.; 2010:83\u2013106."},{"key":"4_CR3","unstructured":"American Psychiatric Association. New Research Abstracts, 161st Annual Meeting of the American Psychiatric Association; May 3\u20138, 2008; Washington, DC."},{"key":"4_CR4","unstructured":"American Psychiatric Association. New Research Abstracts, 162nd Annual Meeting of the American Psychiatric Association; May 16\u201321, 2009; San Francisco, CA."},{"key":"4_CR5","unstructured":"American Psychiatric Association. New Research Abstracts, 163rd Annual Meeting of the American Psychiatric Association; May 22\u201326, 2010; New Orleans, LA."},{"key":"4_CR6","unstructured":"American Psychiatric Association. New Research Abstracts, 164th Annual Meeting of the American Psychiatric Association; May 14\u201318, 2011; Honolulu, HI."},{"key":"4_CR7","unstructured":"American Psychiatric Association. New Research Abstracts, 165th Annual Meeting of the American Psychiatric Association; May 5\u20139, 2012; Philadelphia, PA."},{"key":"4_CR8","unstructured":"American Psychiatric Association. Syllabus and Proceedings Summary, 60th Institute on Psychiatric Services; October 2\u20135, 2008; Chicago, IL."},{"key":"4_CR9","unstructured":"American Psychiatric Association. Syllabus and Proceedings Summary, 61st Institute on Psychiatric Services; October 8\u201311, 2009; New York, NY."},{"key":"4_CR10","unstructured":"American Psychiatric Association. Syllabus and Proceedings Summary, 62nd Institute on Psychiatric Services; October 14\u201317, 2010; Boston, MA."},{"key":"4_CR11","unstructured":"American Psychiatric Association. Syllabus and Proceedings Summary, 63rd Institute on Psychiatric Services; October 27\u201330, 2011; San Francisco, CA."},{"key":"4_CR12","unstructured":"American Psychiatric Association. Syllabus and Proceedings Summary, 64th Institute on Psychiatric Services, New York City, New York, October 4-7, 2012."},{"key":"4_CR13","unstructured":"National Institute of Mental Health and American Society of Clinical Psychopharmacology. Poster Abstracts. 48th Annual NCDEU Meeting; May 27\u201330, 2008; Phoenix, AZ."},{"key":"4_CR14","unstructured":"National Institute of Mental Health and American Society of Clinical Psychopharmacology. Poster Abstracts. 49th Annual NCDEU Meeting; June 29\u2013July 2, 2009; Hollywood, FL."},{"key":"4_CR15","unstructured":"National Institute of Mental Health and American Society of Clinical Psychopharmacology. Poster Abstracts. 50th Annual NCDEU Meeting; June 14\u201317, 2010; Boca Raton, FL."},{"key":"4_CR16","unstructured":"American Society of Clinical Psychopharmacology. Poster Abstracts. 51st Annual NCDEU Meeting; June 14-17, 2011; Boca Raton, FL."},{"key":"4_CR17","unstructured":"American Society of Clinical Psychopharmacology. Poster Abstracts. 52nd Annual NCDEU Meeting; May 29\u2013June 1, 2012; Phoenix, AZ."},{"key":"4_CR18","unstructured":"American College of Neuropsychopharmacology. Program book. 47th Annual Meeting; December 7\u201311, 2008; Scottsdale, AZ."},{"key":"4_CR19","unstructured":"American College of Neuropsychopharmacology. Program book. 48th Annual Meeting; December 6\u201310, 2009; Hollywood, FL."},{"key":"4_CR20","unstructured":"American College of Neuropsychopharmacology. Program book. 49th Annual Meeting; December 5\u20139, 2010; Miami Beach, FL."},{"key":"4_CR21","unstructured":"American College of Neuropsychopharmacology. Program book. 50th Annual Meeting; December 4\u20138, 2011; Waikoloa Beach, HI."},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12325-013-0006-7","volume":"30","author":"L Citrome","year":"2013","unstructured":"Citrome L. Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy. Adv Ther. 2013;30:114\u2013126.","journal-title":"Adv Ther."},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/17425255.2013.759211","volume":"9","author":"L Citrome","year":"2013","unstructured":"Citrome L. Cariprazine: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability. Expert Opin Drug Metab Toxicol. 2013;9:193\u2013206.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","volume":"333","author":"B Kiss","year":"2010","unstructured":"Kiss B, Horv\u00e1th A, N\u00e9methy Z, et al. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther. 2010;333:328\u2013340.","journal-title":"J Pharmacol Exp Ther."},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0924-977X(08)70635-7","volume":"18","author":"M Kapas","year":"2008","unstructured":"Kapas M, Meszaros GP, Yu B, et al. Comparison of the pharmacokinetic behaviour of RGH-188 in schizophrenic patients and healthy volunteers. Eur Neuropsychopharmacol. 2008;18:433.","journal-title":"Eur Neuropsychopharmacol."},{"key":"4_CR26","first-page":"128","volume":"40","author":"N Kirschner","year":"2008","unstructured":"Kirschner N, Gemesi LI, Vastag M, et al. In vitro metabolism of RGH-188. Drug Metab Rev. 2008;40:128\u2013129.","journal-title":"Drug Metab Rev."},{"key":"4_CR27","unstructured":"Knesevich MA, Papadakis K, Bose A, et al. The efficacy and tolerability of cariprazine in acute mania associated with bipolar disorder: a phase II trial. Poster presentation NR1-49, American Psychiatric Association 162nd Annual Meeting; May 16-21, 2009; San Francisco, CA."},{"key":"4_CR28","unstructured":"Starace A, Bose A, Wang Q, et al. Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, Phase III trial. Poster presentation NR9-42, American Psychiatric Association 165th Annual Meeting; May 5\u20139, 2012; Philadelphia, PA."},{"key":"4_CR29","unstructured":"Forest Laboratories, Inc. and Gedeon Richter Plc anounce positive phase III results with the investigational antipsychotic cariprazine in patients with acute mania associated with bipolar I disorder [press release]. Forest Laboratories, Inc.; 8 February 2012. Available at: http:\/\/news.frx.com\/press-release\/product-news\/forest-laboratories-inc-and-gedeon-richter-plc-announce-positive-phase-ii. Accessed November 6 2012."},{"key":"4_CR30","unstructured":"Forest Laboratories, Inc. and Gedeon Richter Plc announce results from a phase II study of cariprazine for the treatment of bipolar depression [press release]. Forest Laboratories, Inc.; 30 August 2010. Available at: http:\/\/news.frx.com\/press-release\/rd-news\/forest-laboratories-inc-and-gedeon-richter-plc-announce-results-phase-ii-stu-0. Accessed November 6 2012."},{"key":"4_CR31","unstructured":"Safety, tolerability, and efficacy of cariprazine for patients with bipolar depression. Forest Laboratories, Inc. ClinicalTrials.gov website. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01396447. Accessed November 6 2012."},{"key":"4_CR32","unstructured":"Safety and efficacy of RGH-188 (cariprazine) in bipolar depression. Forest Laboratories, Inc. ClinicalTrials.gov website. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00852202. Accessed November 6 2012."},{"key":"4_CR33","unstructured":"Long-term safety and tolerability of cariprazine for bipolar I disorder. Forest Laboratories, Inc. ClinicalTrials.gov website. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01059539. Accessed November 6 2012."},{"key":"4_CR34","unstructured":"Geodon (ziprasidone) [product information]. Pfizer, NY, USA; revised October 2012. Available at: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=584. Accessed January 11 2013."},{"key":"4_CR35","unstructured":"Abilify (aripiprazole) [product information]. Otsuka Pharmaceutical Co., Tokyo, Japan; revised February 2012. Available at: http:\/\/www.abilify.com\/pdf\/pi.aspx. Accessed November 12 2012."},{"key":"4_CR36","unstructured":"Saphris (asenapine) [product information]. Merck & Co., NJ, USA; revised October 2012. Available at: http:\/\/www.merck.com\/product\/usa\/pi_circulars\/s\/saphris\/saphris_pi.pdf. Accessed January 11 2013."},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/nedt.2006.2.4.427","volume":"2","author":"L Citrome","year":"2006","unstructured":"Citrome L. A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. Neuropsychiatr Dis Treat. 2006;2:427\u2013443.","journal-title":"Neuropsychiatr Dis Treat."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-013-0004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0004-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T13:48:08Z","timestamp":1714744088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-013-0004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,28]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0004-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,28]]},"assertion":[{"value":"13 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2013","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}